Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
EST sequencing	EFO_0003754	[An assay in which RNA derived from an EST is sequenced]
Bisulfite-seq	EFO_0003753	[An assay in which DNA is the input molecule derived from a bisulphite treatment of DNA to convert cytosine residues to uracil to determine methylation status.]
FL-cDNA	EFO_0003755	[An assay in which RNA derived from a full length cDNA template is sequenced]
Asperger syndrome	EFO_0003757	[An autism spectrum disorder that is characterized by significant difficulties in social interaction, along with restricted and repetitive patterns of behavior and interests. It differs from other autism spectrum disorders by its relative preservation of linguistic and cognitive development., A disorder most often diagnosed in the pediatric years in which the individual displays marked impairment in social interaction and a repetitive, stereotyped pattern of behavior. The individual, however, displays no delay in language or cognitive development, which differentiates Asperger Syndrome from autism.]
GM11831	EFO_0001119
3-methylxanthine	CHEBI_62205	[A monomethylxanthine having the methyl group located at the 3-position. It is a metabolite of caffeine.]
Behcet's syndrome	EFO_0003780	[A chronic, relapsing, multisystemic vasculitis characterized by mucocutaneous lesions, as well as articular, vascular, ocular and central nervous system manifestations., A autoimmune disease of cardiovascular system and is_a vasculitis that causes chronic inflammation in blood vessels throughout the body leading to ulcerations on the mouth and sometimes the genitals, notorious for causing hypopyon uveitis., Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.]
GM11832	EFO_0001120
progressive bulbar palsy	EFO_0003783	[Progressive bulbar palsy involves the brain stem. The brain stem is the part of the brain needed for swallowing, speaking, chewing, and other functions. Signs and symptoms of progressive bulbar palsy include difficulty swallowing, weak jaw and facial muscles, progressive loss of speech, and weakening of the tongue. Additional symptoms include less prominent weakness in the arms and legs, and outbursts of laughing or crying (called emotional lability). Progressive bulbar palsy is considered a variant form of amyotrophic lateral sclerosis (ALS). Many people with progressive bulbar palsy later develop ALS. While there is no cure for progressive bulbar palsy or for ALS, doctors can treat symptoms., A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900)]
GM11839	EFO_0001121
obsolete_allergy	EFO_0003785	[An immune system disease that is an exaggerated immune response to allergens, such as insect venom, dust mites, pollen, pet dander, drugs or some foods., Allergy is any exaggerated immune response to a foreign antigen regardless of mechanism. Thus it includes atopy. Source: Merck Manual, Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.]
GM11881	EFO_0001122
GM11882	EFO_0001123
(+)-dexrazoxane	CHEBI_50223	[A razoxane that has formula C11H16N4O4.]
immunosuppressive agent	CHEBI_35705	[An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.]
GM11992	EFO_0001124
GM11993	EFO_0001125
growth protocol	EFO_0003789	[A growth protocol is a protocol which provides instructions on the growth of a biological sample. E.g. the growth of a specific cell line or Drosophila culture]
GM11994	EFO_0001126
GM11995	EFO_0001127